These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 17425870

  • 21. Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey.
    Kasapoglu B, Turkay C, Bayram Y, Koca C.
    Indian J Med Res; 2010 Jul; 132():56-61. PubMed ID: 20693590
    [Abstract] [Full Text] [Related]

  • 22. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
    Caballería L, Arteaga I, Pera G, Rodríguez L, Alumà A, Auladell MA, Torán P.
    Med Clin (Barc); 2013 Sep 21; 141(6):233-9. PubMed ID: 23601740
    [Abstract] [Full Text] [Related]

  • 23. The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study.
    Gonciarz M, Gonciarz Z, Bielanski W, Mularczyk A, Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2012 Feb 21; 63(1):35-40. PubMed ID: 22460459
    [Abstract] [Full Text] [Related]

  • 24. Liver enzymes and metabolic syndrome: a large-scale case-control study.
    Zhang L, Ma X, Jiang Z, Zhang K, Zhang M, Li Y, Zhao X, Xiong H.
    Oncotarget; 2015 Sep 29; 6(29):26782-8. PubMed ID: 26449189
    [Abstract] [Full Text] [Related]

  • 25. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.
    Jiang LL, Li L, Hong XF, Li YM, Zhang BL.
    Eur J Gastroenterol Hepatol; 2009 Jun 29; 21(6):662-6. PubMed ID: 19282764
    [Abstract] [Full Text] [Related]

  • 26. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G, Sayın I, Polat FB, Çorakçı A, Ataç GK, Değertekin H.
    Turk J Gastroenterol; 2014 Dec 29; 25 Suppl 1():63-8. PubMed ID: 25910371
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association of ALT and the metabolic syndrome among Mexican children.
    Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-González M, Gutiérrez NG, Martínez U.
    Obes Res Clin Pract; 2014 Dec 29; 8(1):e79-87. PubMed ID: 24548580
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM.
    Diabetes; 2005 Nov 29; 54(11):3140-7. PubMed ID: 16249437
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups].
    Nah EH, Park JY.
    Korean J Lab Med; 2008 Jun 29; 28(3):244-50. PubMed ID: 18594178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.